{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:37:51Z","timestamp":1790386671188,"version":"4.1.0"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2013,4,8]],"date-time":"2013-04-08T00:00:00Z","timestamp":1365379200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0060674","type":"journal-article","created":{"date-parts":[[2013,4,8]],"date-time":"2013-04-08T21:08:56Z","timestamp":1365455336000},"page":"e60674","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":52,"title":["Loss of \u03b2-Glucocerebrosidase Activity Does Not Affect Alpha-Synuclein Levels or Lysosomal Function in Neuronal Cells"],"prefix":"10.1371","volume":"8","author":[{"given":"Georgia","family":"Dermentzaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia","family":"Dimitriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Xilouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Michelakakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonidas","family":"Stefanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,4,8]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1136\/jmg.2004.028019","article-title":"Divergent phenotypes in Gaucher disease implicate the role of modifiers","volume":"42","author":"O Goker-Alpan","year":"2005","journal-title":"J Med Genet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ymgme.2004.08.015","article-title":"Gaucher disease: complexity in a "simple" disorder","volume":"83","author":"E Sidransky","year":"2004","journal-title":"Mol Genet Metab"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/qjmed\/89.9.691","article-title":"Occurrence of Parkinson's syndrome in type I Gaucher disease","volume":"89","author":"O Neudorfer","year":"1996","journal-title":"QJM"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease","volume":"361","author":"E Sidransky","year":"2009","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1001\/archneurol.2009.72","article-title":"Mutations for Gaucher disease confer high susceptibility to Parkinson disease","volume":"66","author":"J Mitsui","year":"2009","journal-title":"Arch Neurol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.neulet.2009.01.029","article-title":"Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Greece","volume":"452","author":"K Kalinderi","year":"2009","journal-title":"Neurosci Lett"},{"key":"ref7","first-page":"379","article-title":"Glucocerebrosidase gene mutations: a risk factor for Lewy body disorders","volume":"65","author":"IF Mata","year":"2008","journal-title":"Arch Neurol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.neurobiolaging.2007.11.016","article-title":"Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Portugal","volume":"30","author":"J Bras","year":"2009","journal-title":"Neurobiol Aging"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1093\/brain\/awp044","article-title":"Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease","volume":"132","author":"J Neumann","year":"2009","journal-title":"Brain"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1212\/01.wnl.0000327823.81237.d1","article-title":"Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset","volume":"72","author":"WC Nichols","year":"2009","journal-title":"Neurology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/hmg\/ddq454","article-title":"Large-scale screening of the Gaucher's disease-related glucocerebrosidase gene in Europeans with Parkinson's disease","volume":"20","author":"S Lesage","year":"2011","journal-title":"Hum Mol Genet"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ymgme.2011.06.015","article-title":"beta-Glucocerebrosidase gene mutations in two cohorts of Greek patients with sporadic Parkinson's disease","volume":"104","author":"M Moraitou","year":"2011","journal-title":"Mol Genet Metab"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1126\/science.1101738","article-title":"Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy","volume":"305","author":"AM Cuervo","year":"2004","journal-title":"Science"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"23542","DOI":"10.1074\/jbc.M801992200","article-title":"Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells","volume":"283","author":"T Vogiatzi","year":"2008","journal-title":"J Biol Chem"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1093\/brain\/awm318","article-title":"The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease","volume":"131","author":"T Pan","year":"2008","journal-title":"Brain"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"13621","DOI":"10.1074\/jbc.M109.074617","article-title":"Lysosomal degradation of alpha-synuclein in vivo","volume":"285","author":"SK Mak","year":"2010","journal-title":"J Biol Chem"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ymgme.2004.04.011","article-title":"Neuropathology provides clues to the pathophysiology of Gaucher disease","volume":"82","author":"K Wong","year":"2004","journal-title":"Mol Genet Metab"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00401-010-0741-7","article-title":"Glucocerebrosidase is present in alpha-synuclein inclusions in Lewy body disorders","volume":"120","author":"O Goker-Alpan","year":"2010","journal-title":"Acta Neuropathol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ymgme.2011.06.008","article-title":"Aggregation of alpha-synuclein in brain samples from subjects with glucocerebrosidase mutations","volume":"104","author":"JH Choi","year":"2011","journal-title":"Mol Genet Metab"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"28080","DOI":"10.1074\/jbc.M111.237859","article-title":"Alpha-synuclein interacts with Glucocerebrosidase providing a molecular link between Parkinson and Gaucher diseases","volume":"286","author":"TL Yap","year":"2011","journal-title":"J Biol Chem"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/ana.22400","article-title":"Acid beta-glucosidase mutants linked to Gaucher disease, Parkinson disease, and Lewy body dementia alter alpha-synuclein processing","volume":"69","author":"V Cullen","year":"2011","journal-title":"Ann Neurol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.neuro.2009.06.009","article-title":"Alpha-synuclein-glucocerebrosidase interactions in pharmacological Gaucher models: a biological link between Gaucher disease and parkinsonism","volume":"30","author":"AB Manning-Bog","year":"2009","journal-title":"Neurotoxicology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","article-title":"Gaucher disease glucocerebrosidase and alpha-synuclein form a bidirectional pathogenic loop in synucleinopathies","volume":"146","author":"JR Mazzulli","year":"2011","journal-title":"Cell"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1111\/j.1471-4159.2009.06054.x","article-title":"Inducible over-expression of wild type alpha-synuclein in human neuronal cells leads to caspase-dependent non-apoptotic death","volume":"109","author":"K Vekrellis","year":"2009","journal-title":"J Neurochem"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"6235","DOI":"10.1523\/JNEUROSCI.19-15-06235.1999","article-title":"Caspase-dependent and -independent death of camptothecin-treated embryonic cortical neurons","volume":"19","author":"L Stefanis","year":"1999","journal-title":"J Neurosci"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S1044-7431(03)00201-X","article-title":"Lack of p53 delays apoptosis, but increases ubiquitinated inclusions, in proteasomal inhibitor-treated cultured cortical neurons","volume":"24","author":"P Dietrich","year":"2003","journal-title":"Mol Cell Neurosci"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/mcne.2002.1173","article-title":"Proteasomal inhibition-induced inclusion formation and death in cortical neurons require transcription and ubiquitination","volume":"21","author":"HJ Rideout","year":"2002","journal-title":"Mol Cell Neurosci"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/BF02436006","article-title":"Characterization of glucocerebrosidase in Greek Gaucher disease patients: mutation analysis and biochemical studies","volume":"18","author":"H Michelakakis","year":"1995","journal-title":"J Inherit Metab Dis"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e5515","DOI":"10.1371\/journal.pone.0005515","article-title":"Abberant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy","volume":"4","author":"M Xilouri","year":"2009","journal-title":"PLoS One"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1073\/pnas.0806474106","article-title":"Membrane-associated farnesylated UCH-L1 promotes alpha-synuclein neurotoxicity and is a therapeutic target for Parkinson's disease","volume":"106","author":"Z Liu","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1083\/jcb.142.5.1313","article-title":"Control of neuronal size homeostasis by trophic factor-mediated coupling of protein degradation to protein synthesis","volume":"142","author":"JL Franklin","year":"1998","journal-title":"J Cell Biol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0076-6879(08)03619-7","article-title":"Methods to monitor chaperone-mediated autophagy","volume":"452","author":"S Kaushik","year":"2009","journal-title":"Methods Enzymol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4161\/auto.19496","article-title":"Guidelines for the use and interpretation of assays for monitoring autophagy","volume":"8","author":"DJ Klionsky","year":"2012","journal-title":"Autophagy"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2174\/187152710793237421","article-title":"Autophagy in the central nervous system: implications for neurodegenerative disorders","volume":"9","author":"M Xilouri","year":"2010","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1083\/jcb.137.4.825","article-title":"An intralysosomal hsp70 is required for a selective pathway of lysosomal protein degradation","volume":"137","author":"FA Agarraberes","year":"1997","journal-title":"J Cell Biol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"C1200","DOI":"10.1152\/ajpcell.1995.269.5.C1200","article-title":"Activation of a selective pathway of lysosomal proteolysis in rat liver by prolonged starvation","volume":"269","author":"AM Cuervo","year":"1995","journal-title":"Am J Physiol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1034\/j.1600-0854.2000.010707.x","article-title":"Regulation of lamp2a levels in the lysosomal membrane","volume":"1","author":"AM Cuervo","year":"2000","journal-title":"Traffic"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4161\/auto.2.2.2405","article-title":"p62\/SQSTM1: a missing link between protein aggregates and the autophagy machinery","volume":"2","author":"G Bjorkoy","year":"2006","journal-title":"Autophagy"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"12101","DOI":"10.1073\/pnas.1108197108","article-title":"CNS expression of glucocerebrosidase corrects alpha-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy","volume":"108","author":"SP Sardi","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nm1747","article-title":"Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease","volume":"14","author":"JH Kordower","year":"2008","journal-title":"Nat Med"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"13010","DOI":"10.1073\/pnas.0903691106","article-title":"Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein","volume":"106","author":"P Desplats","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"12571","DOI":"10.1073\/pnas.0906759106","article-title":"Is Parkinson's disease a prion disorder?","volume":"106","author":"CW Olanow","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ymgme.2010.08.004","article-title":"Gaucher disease and parkinsonism, a molecular link theory","volume":"101","author":"E Goldin","year":"2010","journal-title":"Mol Genet Metab"},{"key":"ref44","first-page":"205","article-title":"Increased dimerization of alpha-synuclein in erythrocytes in Gaucher disease and aging. Neurosci Lett","volume":"528","author":"A Argyriou","year":"2012"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.bcmd.2008.03.007","article-title":"Plasmalogen levels in Gaucher disease","volume":"41","author":"M Moraitou","year":"2008","journal-title":"Blood Cells Mol Dis"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0252975","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T00:00:00Z","timestamp":1622764800000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0060674","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T04:25:53Z","timestamp":1562905553000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0060674"}},"subtitle":[],"editor":[{"given":"Patrick","family":"Lewis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,4,8]]},"references-count":45,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,4,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0060674","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,8]]}}}